We are live on ! Find out more
GCTK icon

GlucoTrack
GCTK

18 hedge funds and large institutions have $183K invested in GlucoTrack in 2026 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

77% more capital invested

Capital invested by funds: $104K → $183K (+$79.2K)

38% more funds holding

Funds holding: 13 → 18 (+5)

6.63% less ownership

Funds ownership: 15.81% → 9.18% (-6.6%)

Holders
18
Holders Change
+5
Holders Change %
+38.46%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
2
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
+$103K
2
Jane Street
Jane Street
New York
+$80.5K
3
Citadel Advisors
Citadel Advisors
Florida
+$49.9K
4
VF
Virtu Financial
New York
+$11.7K
5
GIPW
Granite Islands Private Wealth
Connecticut
+$9.84K

Top Sellers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
-$8.02K
2
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust
Pennsylvania
-$3.07K
3
Morgan Stanley
Morgan Stanley
New York
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
HF
1
HRT Financial
New York
$65K +$103K +164,811 +406%
Jane Street
2
Jane Street
New York
$41K +$80.5K +128,459 New
Citadel Advisors
3
Citadel Advisors
Florida
$25.4K +$49.9K +79,530 New
IC
4
Ikarian Capital
Texas
$14.6K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$10.9K -$8.02K -12,794 -27%
VF
6
Virtu Financial
New York
$6K +$11.7K +18,726 New
GIPW
7
Granite Islands Private Wealth
Connecticut
$5.01K +$9.84K +15,700 New
UBS Group
8
UBS Group
Switzerland
$4.26K +$7.92K +12,641 +1,801%
Citigroup
9
Citigroup
New York
$4.11K +$8.07K +12,872 New
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$3.36K +$6.61K +10,546 New
AF
11
Alerus Financial
North Dakota
$1.28K – – –
TRCT
12
Tower Research Capital (TRC)
New York
$1.1K – – –
Barclays
13
Barclays
United Kingdom
$402 +$789 +1,259 New
PF
14
PlanVest Financial
Maryland
$319 +$627 +1,000 New
TCM
15
Tradewinds Capital Management
Washington
$16 +$31 +50 New
NFSG
16
Newbridge Financial Services Group
Florida
$11 – – –
SS
17
SBI Securities
Japan
$3 – – –
Vanguard Fiduciary Trust
18
Vanguard Fiduciary Trust
Pennsylvania
– -$3.07K -4,722 Closed
Morgan Stanley
19
Morgan Stanley
New York
– -$1 -1 Closed

GCTK Hedge Fund Activity: Q2 2026 in Review

18 of the 8,153 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q2 2026, worth a combined $183K — up 77% from $104K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new GCTK positions and 3 closed out — a net gain of 6 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was HRT Financial, adding an estimated $103K. The largest seller was Geode Capital Management, cutting an estimated $8.02K.

  • 18 institutional investors held GlucoTrack (GCTK) as of Q2 2026, up from 13 in Q1 2026.
  • Funds reported $183K of GlucoTrack stock for Q2 2026, up 77% quarter-over-quarter.
  • 9 funds opened new GlucoTrack positions in Q2 2026 and 3 closed out, a net change of +6 holders.
  • The largest GlucoTrack buyer in Q2 2026 was HRT Financial, an estimated $103K added.
  • The largest GlucoTrack seller in Q2 2026 was Geode Capital Management, an estimated $8.02K sold.

Based on aggregated 13F filings for Q2 2026.